FOUNDED IN 1859 BY QUEEN EMMA AND KING KAMEHAMEHA IV

Office of Research and Development

Office of Research and Development
The Queen’s Medical Center
1301 Punchbowl Street, UHT 508
Honolulu, Hawaii 96813

Submit a Study Amendment,
Renewal or Status Report

How to Submit a Study for RIRC/IRB Review

How to Submit a Study Amendment/Modification RIRC/IRB

  1. After the protocol has been given an initial RIRC approval, any subsequent change to the application, protocol or consent form, and any recruitment methods/tools to be used must be reviewed and approved by the RIRC. Submit to either:
    1. Email documents to rirc@queens.org. Word Documents are preferable but PDFs are also acceptable.
    2. Hard Copy:
      1. Prospective: (3) copies of all necessary materials (at least 1 copy single-sided)
      2. Retrospective: (1) single-sided copy
  2. Timeline: All documents should be received 4 weeks prior to the next scheduled meeting of the RIRC.
  3. Please send all hardcopies to:
    Chairman, Research & Institutional Review Committee (RIRC)
    The Queen’s Medical Center
    1301 Punchbowl Street, UH Tower 505
    Honolulu, Hawaii 96813

Study Amendment/Modification

All prospective continuing renewals may also include the following. Provide clean versions for any unchanged document. Provide track change version for any document with any edit.

  • Full Amendment/Revisions/Changes to protocol or informed consent form
  • Recruitment tools/methods – final verbatim text or photo proofs
  • Any other previously stamped approved document that will continue to be used.
  • Any other new study document
  • Summary of Amendment/Revisions/Changes
  • Informed Consent form

Pre-2019 Retrospective continuing renewals may also include the following. Provide clean versions for any unchanged document. Provide track change version for any document with any edit.

  • Full Amendment/Revisions/Changes to protocol or informed consent form
  • Any other pertinent documents

How to Submit a Study Continuing Renewal

Download Form 10
  1. All requests for continuing renewal request must be reviewed and approved by the RIRC.
  2. Fill in Form 10 and collect other required documents (see box to the right)
  3. Submit to either:
    1. Email documents to rirc@queens.org. Word Documents are preferable but PDFs are also acceptable.
    2. Hard Copy:
      1. Prospective: (3) copies of all necessary materials (at least 1 copy single-sided)
      2. Retrospective: (1) single-sided copy
  4. Timeline: All documents should be received 7 weeks prior to the next scheduled meeting of the RIRC.
  5. Please send all hardcopies to:
    Chairman, Research & Institutional Review Committee (RIRC)
    The Queen’s Medical Center
    1301 Punchbowl Street, UH Tower 505
    Honolulu, Hawaii 96813

All Study Renewals

All prospective continuing renewals may also include the following. Provide clean versions for any unchanged document. Provide track change version for any document with any edit.

  • Full Amendment/Revisions/Changes to protocol or informed consent form
  • Recruitment tools/methods – final verbatim text or photo proofs
  • Any other previously stamped approved document that will continue to be used.
  • Any other new study document
  • Summary of Amendment/Revisions/Changes
  • Informed Consent form

Pre-2019 Retrospective continuing renewals may also include the following. Provide clean versions for any unchanged document. Provide track change version for any document with any edit.

  • Full Amendment/Revisions/Changes to protocol or informed consent form
  • Any other pertinent documents

How to Submit a Minimal Risk Study Update/Status Report

  1. All requests for a (post-2018) Minimal Risk Study Update/Status Report must be reviewed the RIRC.
  2. Fill in Form 10B
  3. Submit to either:
    1. Email documents to rirc@queens.org. Word Documents are preferable but PDFs are also acceptable.
    2. Hard Copy:
      1. Prospective: (1) copy of all necessary materials
      2. Retrospective: (1) single-sided copy
  4. Timeline: All documents should be received 7 weeks prior to the next scheduled meeting of the RIRC.
  5. Please send all hardcopies to:
    Chairman, Research & Institutional Review Committee (RIRC)
    The Queen’s Medical Center
    1301 Punchbowl Street, UH Tower 505
    Honolulu, Hawaii 96813

All Minimal Risk Study Update/Status Report

Form 10B: Minimal Risk Continuing Renewal
If you have any questions, please contact
Denise Lin-DeShetler at dlindeshetler@queens.org / 808.691.7986
OR
Rebecca Ohta at rohta@queens.org / 808.691.4512.

The Queen’s Medical Center
Office of Research and Development
1301 Punchbowl Street
UHT 508
Honolulu, Hawaii 96813

Contact Us

Latest News

QMC Research Centers

Related Links

Download Forms

Research Policies and Procedures

Intranet Links

Copyright 1999-2023. Office of Research and Development, The Queen’s Medical Center. Disclaimer

The Queen’s Health System Privacy Policy and Terms of Use

Uniform Guidance

RE: DECLARATION OF PROCUREMENT STANDARDS

The Queen’s Medical Center (QMC) hereby elects to utilize the grace period established in the Office of Management & Budget Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards; final Rule – 2 CFR Chapter I, Chapter II, Part 200, et al. also known as the Uniform Guidance (UG) for July 1, 2015 (FY 16) and continue use of Circular A-110.

Excerpt from § 200.110 (a): “For the procurement standards in §§ 200.317 – 200.326, non-Federal entities may continue to comply with the procurement standards in previous OMB guidance (superseded by this part as described in § 200.104) for two additional fiscal years after this part goes into effect. If a non-Federal entity chooses to use the previous procurement standards for two additional fiscal years before adopting the procurement standards in this part, the non-Federal entity must document this decision in their internal procurement policies.”

In the meantime, QMC shall modify and develop procurement procedures to become consistent with the Uniform Guidance. QMC shall be in compliance with the UG effective July 1, 2018 (FY 19).